🚀 VC round data is live in beta, check it out!
Monsenso Valuation Multiples
Discover revenue and EBITDA valuation multiples for Monsenso and similar public comparables like Telemedycyna Polska, Brain+, Aino Health, Ludwig Enterprises and more.
Monsenso Overview
About Monsenso
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. Its mHealth solution for mental health consists of three components, namely A smartphone app for individuals, A web portal for clinicians & users, and A smartphone app for careers.
Founded
2013
HQ
Employees
13
Website
Sectors
Financials (FY)
EV
$1M
Monsenso Financials
Monsenso reported last fiscal year revenue of $1M and negative EBITDA of ($458K).
In the same fiscal year, Monsenso generated $559K in gross profit, ($458K) in EBITDA losses, and had net loss of ($1M).
Monsenso P&L
In the most recent fiscal year, Monsenso reported revenue of $1M and EBITDA of ($458K).
Monsenso expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $559K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 40% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($458K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (33%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (85%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (81%) | XXX | XXX | XXX |
| Net Debt | — | — | $277K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Monsenso Stock Performance
Monsenso has current market cap of $1M, and enterprise value of $1M.
Market Cap Evolution
Monsenso's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $1M | -4.5% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMonsenso Valuation Multiples
Monsenso trades at 0.8x EV/Revenue multiple, and (2.3x) EV/EBITDA.
Monsenso Financial Valuation Multiples
As of April 4, 2026, Monsenso has market cap of $1M and EV of $1M.
Equity research analysts estimate Monsenso's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Monsenso has a P/E ratio of (1.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.9x | XXX | XXX | XXX |
| P/E | — | XXX | (1.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Monsenso Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Monsenso Margins & Growth Rates
Monsenso's revenue in the last fiscal year declined by (20%).
Monsenso's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Monsenso Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (20%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (33%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 69% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 126% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Monsenso Public Comps
See public comps and valuation multiples for other Healthcare Software and Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Telemedycyna Polska | XXX | XXX | XXX | XXX | XXX | XXX |
| Brain+ | XXX | XXX | XXX | XXX | XXX | XXX |
| Aino Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ludwig Enterprises | XXX | XXX | XXX | XXX | XXX | XXX |
| Kontigo Care | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Monsenso M&A Activity
Monsenso acquired XXX companies to date.
Last acquisition by Monsenso was on XXXXXXXX, XXXXX. Monsenso acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Monsenso
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMonsenso Investment Activity
Monsenso invested in XXX companies to date.
Monsenso made its latest investment on XXXXXXXX, XXXXX. Monsenso invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Monsenso
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Monsenso
| When was Monsenso founded? | Monsenso was founded in 2013. |
| Where is Monsenso headquartered? | Monsenso is headquartered in Denmark. |
| How many employees does Monsenso have? | As of today, Monsenso has over 13 employees. |
| Is Monsenso publicly listed? | Yes, Monsenso is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of Monsenso? | Monsenso trades under MONSO ticker. |
| When did Monsenso go public? | Monsenso went public in 2020. |
| Who are competitors of Monsenso? | Monsenso main competitors are Telemedycyna Polska, Brain+, Aino Health, Ludwig Enterprises. |
| What is the current market cap of Monsenso? | Monsenso's current market cap is $1M. |
| What is the current revenue of Monsenso? | Monsenso's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Monsenso? | Current revenue multiple of Monsenso is 0.8x. |
| Is Monsenso profitable? | No, Monsenso is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.